Moderna seeks full FDA approval for its vaccine

LIFESPAN CORP. Pharmacy Supervisor Richard Emery unpacks the first shipment of Moderna’s COVID-19 vaccine to arrive at Rhode Island Hospital on Dec. 22. / LIFESPAN CORP./BILL MURPHY
MODERNA IS seeking full U.S. regulatory approval for the use of its COVID-19 vaccine in adults. Above, Lifespan Corp. Pharmacy Supervisor Richard Emery unpacks the first shipment of Moderna’s COVID-19 vaccine to arrive at Rhode Island Hospital on Dec. 22, 2020. / COURTESY LIFESPAN CORP./BILL MURPHY
CAMBRIDGE, Mass. – Moderna Inc. says it has begun the process to win full U.S. regulatory approval for the use of its COVID-19 vaccine in adults. The pharmaceutical company announced Tuesday it has begun a “rolling submission” to the U.S. Food and Drug Administration of data from its studies of the two-dose vaccine. Moderna’s vaccine already…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display